Clinical Trial Update: Procedure RElated Outcomes With the Watchman FLX Left Atrial Appendage Closure Device

View source ↗

Summary

The trial evaluating the Watchman FLX left atrial appendage closure device has been withdrawn; it involved patients with atrial fibrillation and stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Watchman FLX Left Atrial Appendage Closure Device

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Atrial Fibrillation, Stroke | Status: WITHDRAWN